Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil

被引：0
|
作者：
Caiyun Li
Luyan Cheng
Xuefang Zhang
Lingli Zhang
Jianzhou Yan
机构：
[1] China Pharmaceutical University,School of International Pharmaceutical Business
[2] China Pharmaceutical University,The Research Center of National Drug Policy and Ecosystem
[3] Nanjing Medical University,School of Pharmacy
来源：
Health Research Policy and Systems | / 22卷
关键词：
Essential medicines for children; Drug labels; China; The Russian Federation; Brazil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list
    Slamang, Waheba
    Scott, Christiaan
    Foster, Helen E.
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [32] Back to the 'essence' of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
    Eniu, Alexandru
    Torode, Julie
    Magrini, Nicola
    Bricalli, Gracemarie
    ESMO OPEN, 2016, 1 (02)
  • [33] National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
    Peacocke, Elizabeth F.
    Myhreid, Sonja L.
    Foss, Hakan Safaralilo
    Gopinathan, Unni
    PLOS MEDICINE, 2022, 19 (03)
  • [34] WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents
    Coghill, David
    Mattingly, Gregory W.
    Rohde, Luis A.
    Wong, Ian C. K.
    Faraone, Steven
    Cortese, Samuele
    LANCET PSYCHIATRY, 2023, 10 (10): : 743 - 744
  • [35] Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011-2021
    Bai, Lin
    Zhan, Yuqi
    Zhou, Yue
    Zhang, Yichen
    Shi, Luwen
    Gupta, Sumit
    Denburg, Avram
    Guan, Xiaodong
    ECLINICALMEDICINE, 2023, 59
  • [36] Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports
    Mahmic-Kaknjo, Mersiha
    Marusic, Ana
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (07) : 825 - 833
  • [37] Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports
    Mersiha Mahmić-Kaknjo
    Ana Marušić
    European Journal of Clinical Pharmacology, 2015, 71 : 825 - 833
  • [38] Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review
    Rashed, Asia N.
    Jackson, Charlotte
    Gastine, Silke
    Hsia, Yingfen
    Bielicki, Julia
    Standing, Joseph F.
    Tomlin, Stephen
    Sharland, Mike
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (12) : 1099 - 1106
  • [39] Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez, SMD
    Hutin, YJE
    Holloway, K
    Gray, R
    Hogerzeil, HV
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1106 - 1113
  • [40] Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
    Walsh, Jennifer
    Masini, Tiziana
    Huttner, Benedikt D.
    Moja, Lorenzo
    Penazzato, Martina
    Cappello, Bernadette
    PHARMACEUTICS, 2022, 14 (03)
12345